Teva Pharmaceutical Industries Ltd., headquartered in Israel, is a leading global pharmaceutical company, committed to providing consumers with access to high-quality healthcare by developing, producing, and marketing affordable generic, innovative, and specialty products, as well as active pharmaceutical ingredients. The world’s largest maker of generic pharmaceutical products, Teva has a global product portfolio of more than 1,300 molecules and a direct presence in approximately 60 countries. The company’s branded businesses focus on products for the central nervous system, oncology, pain, respiratory, women’s health, and biologics.
Teva North America is comprised of subsidiaries of Teva Pharmaceutical Industries Ltd. The North American group has locations in 13 states, the District of Columbia, Canada, and Puerto Rico, and more than 9,000 employees.
Teva North America evaluated several middleware solutions, including IBM WebSphere, when it launched its e-pedigree initiative. “We conducted a thorough evaluation of solutions, and Oracle led the pack in terms of its roadmap, following the acquisition of WebLogic. It also provided strong benchmarks, and we had resources in house that were experienced with Oracle’s solution set, including Oracle E-Business Suite,” said Jagadish Shivaramaiah, manager, applications development, Teva North America.
Teva’s e-pedigree solution―which required four years to build and test―was a ground-breaking initiative involving the integration of numerous systems as well as the deployment of new technologies. For the North American initiative, Teva used Oracle SOA Suite to integrate the company’s Northwest US Distribution Center, packaging lines throughout North America, and downstream trading partners.
After piloting in the United Sates, Teva will roll out its e-pedigree solution at its manufacturing facilities across the globe over the next 18-to-24 months.